Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Hemispherx Biopharma Inc (NYSE MKT LLC:HEB)

0.1253
Delayed Data
As of 3:49pm ET
 +0.003 / +2.45%
Today’s Change
0.06
Today|||52-Week Range
0.20
+55.65%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues213.0K150.0K197.0K133.0K
 
 
 
 
 
Cost of Goods Sold1.3M543.0K555.0K623.0K
 
 
 
 
 
Depreciation And Amortization683.0K691.0K696.0K975.0K
 
 
 
 
 
 
Operating ExpensesGross Income-1.8M-1.1M-1.1M-1.5M
 
 
 
 
 
General Expenses18.6M15.9M17.6M15.0M
 
 
 
 
 
Research And Development9.5M8.2M8.5M7.8M
 
 
 
 
 
Total Operating Expenses20.6M17.1M18.9M16.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-20.3M-17.0M-18.7M-16.4M
 
 
 
 
 
Extraordinary Credit94.0K281.0K14.0K0.00
 
 
 
 
Extraordinary Charge0.00-976.0K-145.0K-315.0K
 
 
 
 
Interest Expense On Debt24.0K159.0K11.0K3.0K
 
 
 
 
 
Other Expenses1.3M686.0K680.0K1.2M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-17.4M-16.2M-17.5M-15.2M
 
 
 
 
 
Net Income-17.4M-16.2M-17.5M-15.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS141.0M167.3M188.3M236.2M
 
 
 
 
 
Shares To Calculate EPS Diluted141.0M167.3M188.3M236.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.12-$0.10-$0.09-$0.06
 
 
 
 
 
EPS Diluted-$0.12-$0.10-$0.09-$0.06